IRIDEX Gross Margin 2010-2024 | IRIX
Current and historical gross margin for IRIDEX (IRIX) over the last 10 years. The current gross profit margin for IRIDEX as of September 30, 2024 is %.
| IRIDEX Gross Margin Historical Data |
| Date |
TTM Revenue |
TTM Gross Profit |
Gross Margin |
| 2024-09-30 |
$0.05B |
$0.02B |
36.73% |
| 2024-06-30 |
$0.05B |
$0.02B |
40.00% |
| 2024-03-31 |
$0.05B |
$0.02B |
40.00% |
| 2023-12-31 |
$0.05B |
$0.02B |
42.31% |
| 2023-09-30 |
$0.06B |
$0.02B |
43.64% |
| 2023-06-30 |
$0.06B |
$0.02B |
42.11% |
| 2023-03-31 |
$0.06B |
$0.03B |
43.10% |
| 2022-12-31 |
$0.06B |
$0.03B |
43.86% |
| 2022-09-30 |
$0.06B |
$0.02B |
42.11% |
| 2022-06-30 |
$0.06B |
$0.02B |
43.64% |
| 2022-03-31 |
$0.05B |
$0.02B |
44.44% |
| 2021-12-31 |
$0.05B |
$0.02B |
43.40% |
| 2021-09-30 |
$0.05B |
$0.02B |
46.00% |
| 2021-06-30 |
$0.05B |
$0.02B |
45.65% |
| 2021-03-31 |
$0.04B |
$0.02B |
43.59% |
| 2020-12-31 |
$0.04B |
$0.02B |
44.44% |
| 2020-09-30 |
$0.04B |
$0.02B |
41.67% |
| 2020-06-30 |
$0.04B |
$0.02B |
39.47% |
| 2020-03-31 |
$0.04B |
$0.02B |
42.86% |
| 2019-12-31 |
$0.04B |
$0.02B |
40.91% |
| 2019-09-30 |
$0.04B |
$0.02B |
41.86% |
| 2019-06-30 |
$0.04B |
$0.02B |
44.19% |
| 2019-03-31 |
$0.04B |
$0.02B |
41.86% |
| 2018-12-31 |
$0.04B |
$0.02B |
42.86% |
| 2018-09-30 |
$0.04B |
$0.02B |
36.59% |
| 2018-06-30 |
$0.04B |
$0.01B |
34.15% |
| 2018-03-31 |
$0.04B |
$0.01B |
34.15% |
| 2017-12-31 |
$0.04B |
$0.01B |
34.15% |
| 2017-09-30 |
$0.04B |
$0.02B |
40.91% |
| 2017-06-30 |
$0.04B |
$0.02B |
41.86% |
| 2017-03-31 |
$0.05B |
$0.02B |
44.44% |
| 2016-12-31 |
$0.05B |
$0.02B |
44.68% |
| 2016-09-30 |
$0.05B |
$0.02B |
43.48% |
| 2016-06-30 |
$0.05B |
$0.02B |
45.65% |
| 2016-03-31 |
$0.04B |
$0.02B |
44.19% |
| 2015-12-31 |
$0.04B |
$0.02B |
45.24% |
| 2015-09-30 |
$0.04B |
$0.02B |
47.62% |
| 2015-06-30 |
$0.04B |
$0.02B |
47.62% |
| 2015-03-31 |
$0.04B |
$0.02B |
47.73% |
| 2014-12-31 |
$0.04B |
$0.02B |
48.84% |
| 2014-09-30 |
$0.04B |
$0.02B |
47.62% |
| 2014-06-30 |
$0.04B |
$0.02B |
47.62% |
| 2014-03-31 |
$0.04B |
$0.02B |
47.50% |
| 2013-12-31 |
$0.04B |
$0.02B |
46.15% |
| 2013-09-30 |
$0.04B |
$0.02B |
45.95% |
| 2013-06-30 |
$0.04B |
$0.02B |
45.71% |
| 2013-03-31 |
$0.03B |
$0.02B |
47.06% |
| 2012-12-31 |
$0.03B |
$0.02B |
48.48% |
| 2012-09-30 |
$0.03B |
$0.02B |
48.48% |
| 2012-06-30 |
$0.03B |
$0.02B |
48.48% |
| 2012-03-31 |
$0.03B |
$0.02B |
48.48% |
| 2011-12-31 |
$0.03B |
$0.02B |
48.48% |
| 2011-09-30 |
$0.03B |
$0.01B |
52.00% |
| 2011-06-30 |
$0.03B |
$0.01B |
50.00% |
| 2011-03-31 |
$0.03B |
$0.02B |
50.00% |
| 2010-12-31 |
$0.03B |
$0.02B |
48.48% |
| 2010-09-30 |
$0.03B |
$0.02B |
48.39% |
| 2010-06-30 |
$0.03B |
$0.02B |
50.00% |
| 2010-03-31 |
$0.03B |
$0.02B |
48.39% |
| 2009-12-31 |
$0.03B |
$0.02B |
48.39% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.029B |
$0.052B |
|
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|
